Analgesics - Latvia

  • Latvia
  • In 2024, the revenue in the Analgesics market in Latvia amounts to US$12.80m.
  • It is projected to grow annually by 9.16% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue in this market, amounting to US$7,243.00m in 2024.
  • Considering the total population figures, per person revenues of US$7.07 are generated in Latvia in 2024.
  • The demand for analgesics in the OTC Pharmaceuticals market in Latvia is driven by a strong preference for locally produced natural remedies.

Key regions: Brazil, Europe, Germany, Canada, United States

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics market in Latvia has been experiencing steady growth in recent years.

Customer preferences:
Latvian consumers have shown a growing preference for over-the-counter analgesics due to their convenience and accessibility. The ease of purchasing these products without a prescription has made them a popular choice for individuals seeking relief from common ailments such as headaches, muscle aches, and minor injuries. Additionally, there is a growing awareness among consumers about the potential side effects of prescription painkillers, leading them to opt for milder and safer options.

Trends in the market:
One notable trend in the Analgesics market in Latvia is the increasing demand for natural and herbal remedies. Consumers are becoming more conscious of the ingredients in the products they use and are seeking alternatives that are perceived to be more natural and less harmful. This trend is in line with the global shift towards natural and organic products in various industries.Another trend in the market is the rise of online sales. With the increasing popularity of e-commerce platforms, consumers are now able to conveniently purchase analgesics online and have them delivered to their doorstep. This has significantly expanded the reach of analgesic products, particularly in rural areas where access to physical pharmacies may be limited.

Local special circumstances:
Latvia has a relatively small population compared to other European countries, which presents both opportunities and challenges for the Analgesics market. On one hand, the smaller market size allows for easier market penetration and targeted marketing strategies. On the other hand, it also means that there is a limited customer base, which may pose challenges in terms of achieving economies of scale.

Underlying macroeconomic factors:
The growing Analgesics market in Latvia can be attributed to several macroeconomic factors. Firstly, the country's improving economy has led to an increase in disposable income, allowing consumers to spend more on healthcare products. Secondly, the aging population in Latvia is driving the demand for analgesics, as older individuals are more likely to experience chronic pain and require pain relief medication. Lastly, the increasing prevalence of sedentary lifestyles and desk jobs has resulted in a higher incidence of musculoskeletal issues, creating a greater need for analgesics.Overall, the Analgesics market in Latvia is experiencing growth due to changing customer preferences, including a shift towards over-the-counter and natural remedies. The rising popularity of online sales and the country's improving economy are also contributing to the market's development. However, the small population size and limited customer base present unique challenges that companies in the market must navigate.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)